Chinese biopharma firm EpimAb bags $74m Series B

Chinese biopharma firm EpimAb bags $74m Series B

05 June, 2019

Epimab Biotherapeutics SDIC Fund Management Sherpa Venture Capital

Printed by Unregistered user on Wed, 10 Dec 2025 09:10:58 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Venture Capital

Shanghai biopharma firm EpimAb raises $25m Series A led by Oriza Seed VC

China’s SDIC, Shenzhen Venture Capital co-lead MabPlex’ $59m Series A

Read more from Greater China

Venture Capital

Temasek, HongShan-backed D3 Bio raises $108m in Series B round

Earnings and Results

Chinese sovereign wealth fund CIC’s profit soars 30.4% on investment gains